The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,092.00
Bid: 12,090.00
Ask: 12,094.00
Change: 42.00 (0.35%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,124.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Britain's FTSE dips after Trump win though pharma, gold miners surge

Wed, 09th Nov 2016 09:58

(ADVISORY- Follow European and UK stock markets in real time onthe Reuters Live Markets blog on Eikon, see cpurl://apps.cp./cms/?pageId=livemarkets)

* FTSE 100 down 0.1 pct

* Gold miners, pharma stocks rally

* U.S.-exposed firms also gain

By Kit Rees

LONDON, Nov 9 (Reuters) - Britain's top share index fell onWednesday after a shock win for Republican Donald Trump in theU.S. presidential election sent markets lower, though goldminers and pharma stocks soared.

Trump defeated favourite Hillary Clinton in Tuesday'selection, putting the U.S. on an uncertain path and promptinginvestors to dump risky assets such as stocks.

The blue chip FTSE 100 index fell 0.1 percent to6,837.87 points by 0932 GMT, having rallied in the previoussession on expectation of a Clinton victory. The moredomestically-focused FTSE 250 index rose 0.2 pct.

The FTSE 100 had opened 2 percent lower, but recovered offits lows. Analysts cited Trump's acceptance speech as soothinginvestor nerves.

"I think the market over-reacted slightly this morning,"John Moore, advisory investment manager at Berkeley Capital,said, adding that he wouldn't be surprised if the FTSE 100turned positive.

"I think Trump is pro-business. The thing is, lookingtowards the FTSE, there are several stocks that will benefitfrom a Trump victory, such as the pharmaceuticals sector.Hillary Clinton wanted to impose tighter regulations, whereasTrump is opposed to that."

Healthcare stocks Hikma, Shire, Astrazeneca and GlaxoSmithKline rallied, gaining between 2percent to 6.7 percent on the back of Trump's win.

Pharma stocks had been losing ground in the run-up to theelection on worries that a Clinton presidency would put pressureon drug prices.

Some companies with significant exposure to the United Statesalso rose. CRH a construction firm which had been toutedas a potential beneficiary from any increase in U.S.infrastructure spending, jumped 7 percent, as it derives 50percent of its revenues from there. U.S.-focused Ashtead also soared 7.6 percent.

Investors' flight to safety buoyed shares in precious metalsminer Fresnillo, which jumped over 9 percent, alongwith Randgold Resources, which gained more than 7percent after the price of gold surged.

Shares in banking stocks, however, came underpressure, while British grocers fell after Sainsbury reported an underwhelming set of results and dropped 3.2percent. The supermarket reported a third straight decline infirst-half profit, hurt by a fall in sales. (Reporting by Kit Rees; Editing by Toby Chopra)

More News
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.